|Alterola Biotech Inc -- USA Stock|| |
USD 1.55 0.00 0.00%
President CEO, Principal Executive Officer, CFO, Principal Financial Officer, Principal Accounting Officer, Director
Mr. Rene Lauritsen is President Chief Executive Officer Principal Executive Officer Chief Financial Officer Principal Financial Officer Principal Accounting Officer Director of Alterola Biotech Inc. Rene Lauritsen holds degrees in business administration from Aarhus Business School and ITadministration from Niels Brock Copenhagen Business School and since graduation he has spent 15 years owning running and working as an independent business consultant at Capital Nordic Limited. Mr Lauritsen area of expertise is working in the information technology field and he has spent this time focusing on helping early and midstage companies meet their objectives.
Age: 41 CEO Since 2014
The company has return on total asset (ROA)
of (133.34) %
which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech Inc has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech is traded on OTC Market in USA.Alterola Biotech Inc (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.